✦ LIBER ✦

Absolute Bioavailability of Subcutaneously Administered Icatibant, a Selective and Potent Bradykinin B2 Receptor Antagonist

✍ Scribed by Wagner, F.; Rosenkranz, B.; Knolle, J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Blocking the bradykinin response: Pharma

✍ Jens Zimmermann; Bernd Rosenkranz; Françoise Brunner-Ferber; Jochen Knolle 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 70 KB

Icatibant, a Potent and Selective Bradyk

✍ Levy, R.J.; Goodman, S. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Inhibition of bradykinin-induced vasodil

✍ JR Cockcroft; PJ Chowienczyk; SE Brett; N Bender; JM Ritter 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 880 KB

LF 16.0335, a novel potent and selective

✍ Didier Pruneau; Jean-Michel Luccarini; Chantal Fouchet; Evelyne Defrêne; Rose-Ma 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 331 KB

Resolution of Symptoms in a Patient with

✍ Boehm, T.; Lumry, W.R. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Safety Evaluation of Icatibant, a Select

✍ Staubach, P.; Bork, K. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 40 KB